<PAGE>

                            UNITED STATES
                  SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.  20549

                              FORM 10-Q

[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
     EXCHANGE ACT OF 1934

              For the quarterly period ended September 30, 1998

                                 OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
     SECURITIES EXCHANGE ACT OF 1934

            For the transition period from N/A to N/A
                                           ---    ---

                      Commission File No. 814-55

TECHNOLOGY FUNDING VENTURE PARTNERS IV, AN AGGRESSIVE GROWTH FUND, L.P.
-----------------------------------------------------------------------
         (Exact name of Registrant as specified in its charter)

          Delaware                         94-3054600
 ------------------------------     ---------------------------------
(State or other jurisdiction of    (I.R.S. Employer Identification No.)
incorporation or organization) 

2000 Alameda de las Pulgas, Suite 250
San Mateo, California                                            94403
-------------------------------------                        ---------
(Address of principal executive offices)                     (Zip Code)

                              (650) 345-2200
             --------------------------------------------------
            (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange 
Act of 1934 during the preceding 12 months (or for such shorter period 
that the registrant was required to file such reports), and (2) has been 
subject to such filing requirements for the past 90 days.  Yes X  No 
                                                              ---   --- 
No active market for the units of limited partnership interests 
("Units") exists, and therefore the market value of such Units cannot be 
determined.


<PAGE>

I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

BALANCE SHEETS
--------------

<TABLE>
<CAPTION>

                                        (unaudited)
                                        September 30,       December 31,
                                            1998               1997
                                        ------------        -----------
<S>                                     <C>                 <C>
ASSETS

Investments:
 Equity investments (cost basis
  of $12,859,924 and $12,492,981 for
  1998 and 1997, respectively)          $15,131,301         14,234,001
 Notes receivable                                --              4,501
                                         ----------         ----------
     Total investments                   15,131,301         14,238,502

Cash and cash equivalents                 3,121,432          8,821,077
Due from related parties                        875                 --
Other assets                                  5,019             10,100
                                         ----------         ----------

     Total assets                       $18,258,627         23,069,679
                                         ==========         ==========

LIABILITIES AND PARTNERS' CAPITAL

Accounts payable and accrued expenses   $    37,050             47,799
Due to related parties                           --            119,285
Distributions payable                     1,386,755          3,544,571
Other liabilities                            17,162              3,736
                                         ----------         ----------

     Total liabilities                    1,440,967          3,715,391

Commitments, contingencies and 
 subsequent event
 (Notes 2, 3, 5 and 6)

Partners' capital:
 Limited Partners
  (Units outstanding of 400,000
  for both 1998 and 1997)                14,047,738         16,288,081
 Managing General Partners                  498,545          1,325,187
 Net unrealized fair value increase
  from cost of equity investments         2,271,377          1,741,020
                                         ----------         ----------

     Total partners' capital             16,817,660         19,354,288
                                         ----------         ----------

     Total liabilities and
      partners' capital                 $18,258,627         23,069,679
                                         ==========         ==========
</TABLE>

See accompanying notes to financial statements.

<PAGE>
STATEMENTS OF OPERATIONS (unaudited)
-----------------------------------
<TABLE>
<CAPTION>
                                               For the Three                 For the Nine
                                               Months Ended                  Months Ended
                                               September 30,                 September 30,
                                        -------------------------       ----------------------
                                            1998          1997            1998          1997
                                            ----          ----            ----          ----
<S>                                   <C>             <C>             <C>          <C>
Income:
 Notes receivable interest             $    4,954          2,340           4,954       17,685
 Short-term investment interest            25,794         39,439          86,388       85,348
                                        ---------      ---------       ---------   ----------
  Total income                             30,748         41,779          91,342      103,033


Costs and expenses:
 Management fees                           57,293         64,617         164,392      235,981
 Individual General Partners' 
  compensation                             14,031         10,500          33,947       35,401
 Operating expenses                       473,648        312,249       1,142,040      848,839
                                        ---------      ---------       ---------   ----------

  Total costs and expenses                544,972        387,366       1,340,379    1,120,221
                                        ---------      ---------       ---------   ----------

Net operating loss                       (514,224)      (345,587)     (1,249,037)  (1,017,188)

 Net realized gain (loss) from 
  sales of equity investments             287,163        (31,129)        178,402    3,417,413
 Net realized gain from venture
  capital limited partnership
  investments                                  --        100,419              --      514,050
 Recoveries from investments
  previously written off                       --             --           3,650           --


 Realized losses from 
  investment write-downs                       --     (3,146,346)             --   (3,146,346)
                                        ---------      ---------       ---------   ----------
Net realized loss                        (227,061)    (3,422,643)     (1,066,985)    (232,071)

Change in net unrealized 
  fair value of equity investments     (2,221,396)     1,970,382         530,357  (10,927,781)
                                        ---------      ---------       ---------   ----------

Net loss                              $(2,448,457)    (1,452,261)       (536,628) (11,159,852)
                                        =========      =========       =========   ==========

Net realized loss per unit             $       --             (7)             (2)          --
                                        =========      =========       =========   ==========
</TABLE>

See accompanying notes to financial statements.

<PAGE>
STATEMENTS OF CASH FLOWS (unaudited)
-----------------------------------
<TABLE>
<CAPTION>
                                                For the Nine Months
                                                Ended September 30,
                                          -----------------------------
                                             1998                1997
                                          ----------         ----------
<S>                                      <C>                 <C>
Cash flows from operating activities:
 Interest received                      $   86,504              96,780
 Interest paid                                  --             (42,976)
 Cash paid to vendors                     (162,608)           (261,346)
 Cash paid to related parties           (1,290,173)           (954,079)
                                         ---------           ---------

  Net cash used by operating activities (1,366,277)         (1,161,621)
                                         ---------           ---------

Cash flows from investing activities:
 Notes receivable issued                   (16,598)           (150,500)
 Purchase of equity investments           (979,997)         (1,619,510)
 Repayments of equity investments 
  and notes receivable                     204,848              11,678
 Proceeds from sales of equity
  investments                              612,545           8,273,094
 Recoveries from investments
  previously written off                     3,650                  --
 Distributions from venture capital
  limited partnerships                          --              19,709
                                         ---------           ---------

  Net cash (used) provided by 
   investing activities                   (175,552)          6,534,471
                                         ---------           ---------

Cash flows from financing activities:
  Distribution to partners              (4,157,816)                 --
  Repayments of promissory notes                --          (1,363,332)
                                         ---------           ---------

  Net cash used by financing 
   activities                           (4,157,816)         (1,363,332)
                                         ---------           ---------

Net (decrease) increase in cash
  and cash equivalents                  (5,699,645)          4,009,518

Cash and cash equivalents at 
  beginning of year                      8,821,077           1,402,668
                                         ---------           ---------
Cash and cash equivalents               $3,121,432           5,412,186
  at September 30                        =========           =========

See accompanying notes to financial statements.
</TABLE>

<PAGE>

STATEMENTS OF CASH FLOWS (unaudited)(continued)
-----------------------------------------------
<TABLE>
<CAPTION>
                                              For the Nine Months
                                              Ended September 30,
                                        -------------------------------
                                            1998                1997
                                        -----------         -----------
<S>                                    <C>                   <C>
Reconciliation of net loss to 
 net cash used by operating activities:

Net loss                                $ (536,628)        (11,159,852)

Adjustments to reconcile net loss to net
 cash used by operating activities:
  Realized losses from investment
   write-downs                                  --           3,146,346
  Net realized gain from sales 
   of equity investments                  (178,402)         (3,417,413)
  Net realized gain from venture
   capital limited partnership
   investments                                  --            (514,050)
  Recoveries from investments
   previously written off                   (3,650)                 --
  Change in net unrealized fair value 
   of equity investments                  (530,357)         10,927,781

Changes in:
 Due to/from related parties              (120,160)            (90,496)
 Other changes, net                          2,920             (53,937)
                                         ---------           ---------
Net cash used by operating activities  $(1,366,277)         (1,161,621)
                                         =========           =========

</TABLE>

See accompanying notes to financial statements.

<PAGE>

NOTES TO FINANCIAL STATEMENTS (unaudited)
----------------------------------------

1.     General
       -------

In the opinion of the Managing General Partners, the accompanying interim 
financial statements reflect all adjustments necessary for a fair 
presentation of the financial position, results of operations, and cash 
flows for the interim periods presented.  These statements should be read 
in conjunction with the Annual Report on Form 10-K for the year ended 
December 31, 1997.  Allocation of income and loss to Limited and General 
Partners is based on cumulative income and loss.  Adjustments, if any, are 
reflected in the current quarter balances.

2.     Related Party Transactions
       --------------------------

Related party costs are included in costs and expenses shown on the 
Statements of Operations.  Related party costs for the nine months ended 
September 30, 1998 and 1997, were as follows:

<TABLE>
<CAPTION>
                                                 1998          1997
                                               --------      --------
   <S>                                        <C>            <C>
   Management fees                            $164,392       235,981
   Individual General Partners' compensation    33,947        35,401
   Reimbursable operating expenses             971,674       592,201

</TABLE>

Certain reimbursable expenses have been accrued based upon interim 
estimates prepared by the Managing General Partners and are adjusted to 
actual periodically.  There were $22,659 due from related parties at 
September 30, 1998 and $78,672 due to related parties at December 31, 1997, 
for such expenses.

Amounts payable for management fees were $21,784 and $40,613 at September 
30, 1998, and December 31, 1997, respectively.  Pursuant to the Partnership 
Agreement, quarterly management fees are equal to one quarter of one 
percent of the fair value of Partnership assets.

Officers of the Managing General Partners occasionally receive stock 
options as compensation for serving on the Boards of Directors of portfolio 
companies.  At September 30, 1998, the Partnership had an indirect interest 
in Endocare, Inc. and Physiometrix, Inc. non-transferable options at an 
exercise price higher than the current market value.

The Managing General Partners allocate operating expenses incurred in 
connection with the business of the Partnership based on employee hours 
incurred.  In the third quarter of 1998, the Managing General Partners 
reevaluated allocations to the Partnership and determined that they had not 
fully recovered allocable operating expenses, primarily salary and 
benefits, as permitted by the Partnership Agreement. As a result, the 
Partnership was charged additional operating expenses in the third quarter 
of 1998 of $180,598 consisting of $16,683 for the nine months ended 
September 30, 1997 and $163,915 for prior years.  Had the additional 
expenses been recorded in prior years, total operating expenses for the 
three months ended September 30, 1998 and 1997 would have been $293,050 and 
$328,932, respectively, and total operating expenses for the nine months 
ended September 30, 1998 and 1997 would have been $961,442 and $865,522, 
respectively.


<PAGE>

3.     Equity Investments
       ------------------
<TABLE>
A full listing of the Partnership's equity investments at December 31, 1997 is in the 1997 Annual 
Report.  Activity from January 1 through September 30, 1998 consisted of:
<CAPTION>

                                                                            January 1 through
                                                                            September 30, 1998
                                                                         -------------------------
                                                            Principal
                                          Investment        Amount or      Cost           Fair
Industry/Company         Position            Date             Shares       Basis          Value
-----------------       ----------       ------------      -----------   ----------     ----------
<S>                    <C>                 <C>              <C>            <C>         <C>
Balance at January 1, 1998                                              $12,492,981     14,234,001
                                                                         ----------     ----------

Significant changes:

Communications
--------------
NetChannel,             Series B
 Inc.                   Preferred            10/96-
                        shares               05/97          1,100,757      (384,398)      (581,293)
NetChannel,             Convertible
 Inc.                   notes               various          $180,172      (185,309)      (185,309)
NetChannel,             Escrowed sales
 Inc.                   proceeds             06/98            $74,761        74,761         74,761
Women.com               Series D
 Networks               Preferred
                        shares               06/98             91,185       299,999        299,999

Computer Equipment, Systems and Software
----------------------------------------
Adept Technology,       Common
 Inc.                   shares               10/97            14,328              0        (52,369)
Splash Technology,      Escrowed sales
 Holdings, Inc.         proceeds             05/97           $95,000              0       (280,000)


Environmental 
-------------
Thermatrix,             Common               06/96          1,105,847             0      1,188,721
 Inc.                   shares

Medical/Biotechnology
---------------------
CV Therapeutics         Common
 Inc.                   shares              various            37,693             0       (107,123)
Endocare,               Common
 Inc.                   shares               04/98             35,714       124,999         91,071
Neurex                  Common
 Corporation            shares               09/96              3,379       (70,959)       (45,448)
Periodontix,            Series C
 Inc.                   Preferred shares     02/98            106,122       259,999        259,999
Physiometrix,           Common
 Inc.                   shares               04/96            270,791             0       (138,980)
Urogen                  Convertible
 Corporation            note (1)             06/98           $250,000       250,000        250,000

Retail/Consumer Products
------------------------
Yes! Entertainment      Common
 Corporation            shares               06/95             66,666             0        (89,799)

Venture Capital Limited Partnership Investments
-----------------------------------------------
Various                 Limited
                        Partnership
                        Interests           various        $2,303,764        (2,683)       239,478
                                                                         ----------     ----------

Total significant changes during the nine
months ended September 30, 1998                                             366,409        923,708

Other changes, net                                                              534        (26,408)
                                                                         ----------     ----------
Total equity investments at September 30, 1998                          $12,859,924     15,131,301
                                                                         ==========     ==========

(1)  Convertible notes include accrued interest.  The interest rate on notes issued in 1998 was 8%.

</TABLE>


Marketable Equity Securities
----------------------------

At September 30, 1998, and December 31, 1997, marketable equity securities 
had aggregate costs of $3,181,212 and $3,157,615, respectively, and 
aggregate market values of $2,481,361 and $2,414,032, respectively.  The 
net unrealized losses at September 30, 1998 and December 31, 1997 included 
gross gains of $420,742 and $350,879, respectively.

Endocare, Inc.
--------------

In April 1998, the Partnership purchased 35,714 common shares for $124,999 
in a private placement.  At September 30, 1998, the Partnership recorded a 
$44,595 decrease in the fair value of its investment based on the publicly-
traded market price of the company's common shares.

NetChannel, Inc.
----------------

In June 1998, America Online, Inc., completed its acquisition of the 
company.  The Partnership realized a loss of $89,873 on the completion  of 
the sale transaction.  Proceeds of $219,762 and $204,848 were received from 
the sale of the Partnership's preferred shares and repayment of convertible 
and other notes receivable. An amount of $74,761 in future sale proceeds 
will remain in escrow through December 1999 pending final resolution of the 
sale.

Neurex, Inc.
------------

In February 1998, the Partnership sold 3,379 common shares for total 
proceeds of $61,884 and realized a loss of $9,075.

Periodontix, Inc.
-----------------

In February 1998, the Partnership purchased 106,122 Series C Preferred 
shares for $259,999.

Splash Technology Holdings, Inc.
--------------------------------

In August 1998, the Partnership realized a gain of $281,625 on receipt of 
previously escrowed sales proceeds which arose from the sale of its 
investment in Quintar Corporation to the company.

Urogen Corporation
------------------

In June 1998, the Partnership issued $250,000 in convertible notes 
receivable to the company and received a warrant to purchase 125,000 common 
shares at $0.74 per share prior to June, 2005.

Women.com Networks (formerly Wire Networks, Inc.)
-----------------------------------------------

In February 1998, the company changed its name from Wire Networks, Inc. to 
Women.com Networks.  In June 1998, the Partnership made an additional 
investment in the company by purchasing 91,185 Series D Preferred shares 
for $299,999.  The pricing of this round, in which third parties 
participated, indicated a $12,210 increase in the fair value of the 
Partnership's existing investment.

Venture Capital Limited Partnerships
------------------------------------

The Partnership made additional investments totaling $45,000 in venture 
capital limited partnerships during the nine months ended September, 1998.  
The Partnership also received stock distributions of Hybridon, Inc. and 
Neurex Corporation with fair values of $42,161 and $5,522, respectively, 
which were recorded as returns of capital.

The Partnership recorded a $239,748 increase in fair value as a result of a 
net increase in the fair value of the underlying investments.

Other Equity Investments
------------------------

Other significant changes reflected above relate to market value 
fluctuations or the elimination of a discount relating to selling 
restrictions for publicly traded portfolio companies.  Portions of the 
Partnership's Physiometrix, Inc. and Thermatrix, Inc. shares are 
restricted.

Subsequent to quarter end, the fair value of the Partnership's Thermatrix, 
Inc. investment increased by $858,466 as a result of an increase in the 
publicly-traded market price at November 10, 1998.

4.     Cash and Cash Equivalents
       -------------------------

Cash and cash equivalents at September 30, 1998 and December 31, 1997 
consisted of:
<TABLE>
                                                 1998             1997
                                                ------           ------
<S>                                           <C>              <C>   

Demand accounts                             $   41,079         5,543,116
Money-Market accounts                        3,080,353         3,277,961
                                             ---------         ---------
     Total                                  $3,121,432         8,821,077
                                             =========         =========

At September 30, 1998, the majority of the money market funds were on 
deposit at a single financial institution.

</TABLE>


5.     Distributions
       -------------

In September 1998, the Managing General Partners declared distributions 
($3.47 per unit) for unit holders as of July 2, 1998.  Distributions of 
$613,245 were paid in September 1998 and the balance of $1,386,755 will be 
paid in the fourth quarter of 1998.  Unnegotiated distribution checks, if 
any after a reasonable amount of time, are recorded as other liabilities.

In October 1997, the Managing General Partners declared distributions ($9 
per unit) for Unit holders as of September 30, 1997.  Distributions of 
$455,429 were paid prior to December 31, 1997 and the balance of $3,544,571 
was paid in February 1998.


6.     Commitments and Contingencies
       -----------------------------

The Partnership is a party to financial instruments with off-balance-sheet 
risk in the normal course of its business.  Generally, these instruments 
are commitments for future equity fundings, venture capital limited 
partnership investments, equipment financing commitments, or accounts 
receivable lines of credit that are outstanding but not currently fully 
utilized.  As they do not represent current outstanding balances, these 
unfunded commitments are properly not recognized in the financial 
statements.  At September 30, 1998, the Partnership had unfunded 
commitments as follows:

<TABLE>
<CAPTION>

Type
----
<S>                                                       <C>
Equity investments                                        $337,750
Venture capital limited partnership investments             56,150
                                                           -------
                                                          $393,900
                                                           =======
</TABLE>

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations

Liquidity and Capital Resources
-------------------------------

During the nine months ended September 30, 1998, net cash used by operating 
activities totaled $1,366,277.  The Partnership paid management fees of 
$183,221 to the Managing General Partners and reimbursed related parties 
for operating expenses of $1,073,005 in 1998.  In addition, $33,947 was 
paid to the Individual General Partners as compensation for their services.  
Other operating expenses of $162,608 were paid and interest income of 
$86,504 was received.

During the nine months ended September 30, 1998, the Partnership funded 
equity investments of $979,997 mostly to portfolio companies in the 
medical/ biotechnology and communications industries.  Proceeds from the 
sales of equity investments were $612,545 and repayments of equity 
investments and notes receivable totaled $204,848.  Distributions to 
partners of $4,157,816 were paid.  At September 30, 1998, the Partnership 
had distributions payable of $1,386,755 and was committed to fund $393,900 
in additional investments.

Cash and cash equivalents at September 30, 1998, were $3,121,432.  Future 
proceeds from investment sales and interest income on short-term 
investments are expected to be adequate to fund Partnership operations 
through the next twelve months.

Results of Operations
---------------------

Current quarter compared to corresponding quarter in the preceding year
-----------------------------------------------------------------------

Net loss was $2,448,457 for the quarter ended September 30, 1998, compared 
to a net loss of $1,452,261 during the same period in 1997.  The change was 
primarily due to a decrease of $4,191,778 in net unrealized fair value of 
equity investments, partially offset by a $3,146,346 decrease in realized 
losses from investment write-downs.

During the quarter ended September 30, 1998, the decrease in equity 
investment fair value of $2,221,396 was primarily attributable to a 
decrease in a portfolio company in the environmental industry.  During the 
same period in 1997, the increase in fair value of equity investments of 
$1,970,382 was primarily attributable to increases in portfolio companies 
in the computer systems and software and pharmaceuticals industries.

Net realized losses from investment write-downs of $3,146,346 for the 
quarter ended September 30, 1997, related to a portfolio company in the 
computer systems and software industry.

As disclosed in Note 2 to the financial statements, operating expenses for 
the three months ended September 30, 1998 include additional expenses of 
$180,598 related to prior years which were not previously charged to the 
Partnership.  Had the additional expenses been recorded in prior years, 
operating expenses for the quarters ended September 30, 1998 and 1997 would 
have been $293,050 and $328,932, respectively.  The decrease is 
attributable to decreased administrative and investor services expenses due 
to decreased levels of investment activity.

Given the inherent risk associated with the business of the Partnership, 
the future performance of the portfolio company investments may 
significantly impact future operations.

Current nine months compared to corresponding nine months in the preceding
------------------------------------------------------------------------
year
----

Net loss was $536,628 for the nine months ended September 30, 1998, 
compared to a net loss of $11,159,852 during the same period in 1997. The 
change was primarily due to an increase of $11,458,138 in the net 
unrealized fair value of equity investments, and a $3,146,346 decrease in 
realized losses from investment write-downs, partially offset by a 
$3,239,011 decrease in realized gains from the sales of equity investments.

During the nine months ended September 30, 1998, the increase in equity 
investment fair value of $530,357 was mainly attributable to a portfolio 
company in the environmental industry.  During the same period in 1997, the 
decrease of $10,927,781 was primarily attributable to portfolio companies 
in the environmental, computer systems and software, and pharmaceuticals 
industries, partially offset by increases in portfolio companies in the 
communications industries.

Net realized losses from investment write-downs of $3,146,346 for the nine 
months ended September 30, 1997 related to a portfolio company in the 
computer systems and software industry.

During the nine months ended September 30, 1998, net realized gain on sales 
of equity investments was $178,402 primarily related to the receipt of 
escrowed sales proceeds from Splash Technology Holdings, Inc., partially 
offset by a loss on the sale of NetChannel, Inc.  A net realized gain from 
sales of equity investments of $3,417,413 during the same period in 1997 
was primarily due to the common stock sales of SyStemix, Inc., and Shaman 
Pharmaceuticals, Inc.

Total operating expenses were $1,142,040 and $848,839 for the nine months 
ended September 30, 1998 and 1997, respectively.  As disclosed in Note 2 to 
the financial statements, operating expenses for the nine months ended 
September 30, 1998 include additional expenses of $180,598 related to prior 
years which were not previously charged to the Partnership.  Had the 
additional expenses been recorded in prior years, operating expenses for 
the nine months ended September 30, 1998 and 1997 would have been $961,442 
and $865,522, respectively.  The increase is attributable to increased 
administrative and investors services expenses due to increased levels of 
investment monitoring activity and increased computer expenses.

The Year 2000
-------------

The widespread use of computer programs that rely on two-digit date 
programs to perform computations and decision-making functions may cause 
computer systems to malfunction in the year 2000 and lead to significant 
business delays and disruptions.  

The Managing General Partners have completed a preliminary assessment of 
the internal financial, information and operating systems which it provides 
to the Partnership.  Implementation and testing of necessary system 
modifications is in progress and will be completed well before December 31, 
1999.  The Managing General Partners are also monitoring the progress of 
software vendors and third-party processors on which they rely, as well as 
the progress of portfolio companies in which the Partnership has made 
significant investments.  

The Managing General Partners do not expect the cost of the internal system 
modifications to be material to the Partnership's financial 
statements.

II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

a) No reports on Form 8-K were filed by the Partnership during the 
quarter ended September 30, 1998.
 
b) Financial Data Schedule for the nine months ended and as of September 
30, 1998 (Exhibit 27).
 


<PAGE>




                              SIGNATURES
                              ----------

Pursuant to the requirements of Section 13 or 15(d) of the Securities 
Exchange Act of 1934, the Registrant has duly caused this Report to be 
signed on its behalf by the undersigned, thereunto duly authorized.

                         TECHNOLOGY FUNDING VENTURE PARTNERS IV, 
                         AN AGGRESSIVE GROWTH FUND, L.P.

                         By:  TECHNOLOGY FUNDING INC.
                              Managing General Partner




Date:  November 12, 1998   By:      /s/Michael R. Brenner
                              -----------------------------------------
                                       Michael R. Brenner
                                       Controller